Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7576 - 7600 of 8116 in total
Ertiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 diabetes. In insulin-resistant rodent models, ertiprotafib and a close analog lowered both fasting blood glucose and insulin levels and improved glycemic excursion during an oral glucose tolerance test.
Investigational
Displaying drugs 7576 - 7600 of 8116 in total